TransCode Therapeutics Enters into Agreements for up to $20 Million Flexible Financing, Extending Company’s Runway into Late 2027/Early 2028
April 7, 2026
Evofem Appoints Ivy Zhang as Chief Financial Officer and Secretary
April 14, 2023
Related Post
-
-
AI-Driven Compliance Gamechanger in Pharma Manufacturing and Regulatory Standards
April 7, 2026
-
Akari Therapeutics Announces Strategic Partnership with WuXi XDC to Advance Development of Its Novel ADC Payload Targeting RNA Splicing
April 6, 2026
-
Quantum-Si Announces the Start of the Proteus(TM) Roadshow
April 6, 2026